Table 1. The baseline characteristics of the study population.
Baseline characteristics | AMD, n = 72 |
Mean age – years ± SD | 73.9±8.3 |
Sex, male – No. (%) | 29 (40.3) |
Visual acuity OD – median (1st–3rd quartile) | 20/83 (20/400–20/25) |
Visual acuity OS – median (1st–3rd quartile) | 20/55 (20/333–20/26) |
Mean C3d/C3 ratio ± SD | 1.65±0.69 |
Mean zinc level – µmol/l ± SD | 13.33±2.83 |
CFH (Y402H; rs1061170) genotypes, No. (%) | |
CFH TT genotype (wildtype) | 1 (1.4) |
CFH CT genotype | 36 (50.0) |
CFH CC genotype | 34 (47.2) |
ARMS2 (A69S; rs10490924) genotypes, No. (%) | |
ARMS2 GG genotype (wildtype) | 19 (26.4) |
ARMS2 TG genotype | 30 (41.7) |
ARMS2 TT genotype | 22 (30.6) |
Serum C-reactive protein (CRP), No. (%) | |
<5 – mg/l | 52 (72.2) |
5–15 – mg/l | 18 (25.0) |
16–45 – mg/l | 2 (2.8) |
SD = Standard deviation, visual acuity in Snellen.